The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.
The visit included working sessions focused on upcoming trials and regulatory planning, as well as our AI-powered medical device project for the early detection of congenital heart defects. These conversations are helping shape the next steps in our clinical development roadmap.
We also continued preparations for opening our new U.S. office — a move that will strengthen our ability to work closely with sponsors and research teams in North America.
Beyond the meetings, the trip offered space for team reflection and strategic thinking — sometimes the best ideas come outside of meeting rooms.
Thank you to everyone who took the time to meet with us. We look forward to continuing the conversations and turning shared plans into action.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant